The Lovesac Company Announces Participation in the 2025 ICR Conference
STAMFORD, Conn., Jan. 07, 2025 (GLOBE NEWSWIRE) — The Lovesac Company (Nasdaq: LOVE) (“Lovesac” or the “Company”), the home furnishing […]
Glucotrack to Present at TechBio Showcase™ 2025
RUTHERFORD, N.J., Jan. 07, 2025 (GLOBE NEWSWIRE) — Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical technology company […]
CAMP4 Provides Corporate Updates and Highlights Key Upcoming Milestones
Data from Single Ascending Dose (SAD) portion of Phase 1 study of CMP-CPS-001 for the treatment of urea cycle disorders […]
Robinhood Markets, Inc. to Announce Fourth Quarter and Full Year 2024 Results on February 12, 2025
MENLO PARK, Calif., Jan. 07, 2025 (GLOBE NEWSWIRE) — Today, Robinhood Markets, Inc. (“Robinhood”) (NASDAQ: HOOD) announced that it will […]
BBSI Earns Great Place To Work® Certification for Fourth Consecutive Year, Celebrating a Thriving Workplace Culture
VANCOUVER, Wash., Jan. 07, 2025 (GLOBE NEWSWIRE) — Barrett Business Services, Inc. (BBSI) (NASDAQ: BBSI), a leading provider of business […]
Regeneron to Report Fourth Quarter and Full Year 2024 Financial and Operating Results and Host Conference Call and Webcast on February 4, 2025
TARRYTOWN, N.Y., Jan. 07, 2025 (GLOBE NEWSWIRE) — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that it will report its […]
Getty Realty Corp. Provides 2024 Business Update
– Invested More Than $200 Million in Convenience and Automotive Retail Assets – – Introduces 2025 Earnings Guidance – NEW […]
Crane NXT to Participate in the CJS Securities 25th Annual New Ideas for the New Year Conference
WALTHAM, Mass., Jan. 07, 2025 (GLOBE NEWSWIRE) — Crane NXT, Co. (NYSE: CXT), a premier industrial technology company, announced that […]
Corvus Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference
BURLINGAME, Calif., Jan. 07, 2025 (GLOBE NEWSWIRE) — Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today announced that Richard A. […]
Caribou Biosciences to Present at 43rd Annual J.P. Morgan Healthcare Conference
BERKELEY, Calif., Jan. 07, 2025 (GLOBE NEWSWIRE) — Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, […]
